CLIC-2201 for the Treatment of Relapsed/Refractory B Cell Malignancies
Condition(s):B-Cell Leukemia; Non-Hodgkin’s Lymphoma; B-cell Acute Lymphoblastic Leukemia; Diffuse Large B Cell Lymphoma; High-grade B-cell Lymphoma; Primary Mediastinal Large B-cell Lymphoma (PMBCL); Mantle Cell Lymphoma; B-cell LymphomaLast Updated:January 17, 2024Not yet recruiting